Long-term safety of azathioprine for treatment of neuromyelitis optica spectrum disorders
ABSTRACT Background: Azathioprine is a common first-line therapy for neuromyelitis optica spectrum disorder (NMOSD). Objective: The aim of this study was to determine whether long-term treatment (>10 years) with azathioprine is safe in NMOSD. Methods: We conducted a retrospective medical record...
Guardat en:
| Autors principals: | , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Thieme Revinter Publicações
2021-03-01
|
| Col·lecció: | Arquivos de Neuro-Psiquiatria |
| Matèries: | |
| Accés en línia: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2021000300229&tlng=en |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|